MEET US 2025

DG-GT Meeting: Dresden, DE | 10-11 Mar 2025

|

BIO CHINA 2025: Suzhou, CHN | 13-15 Mar 2025

|

BIO-Europe Spring: Milan, IT | 25-26 Mar 2025

|

German Pharm-Tox Summit: Hannover, DE | 25-28 Mar 2025

|

German Biotech Days: Heidelberg, DE | 09-10 Apr 2025

|

MEET2WIN: Bourdeaux, FR | 06-07 May 2025

|

BIO KOREA 2025: Seoul, KR | 07-09 May 2025

|

BIONNALE 2025: Berlin, DE | 14-15 May 2025

|

Innovation for Cell and Gene Therapies (ICGT): Paris, FR | 22 May 2025

|

MabDesign Partnering Day: Lyon, FR | 02 Jun 2025

|

Congrès Polepharma Biotesting: Evreux, FR | 04-05 Jun 2025

|

International Oligonucleotides and Peptides Conference: Prague, CZ | 09-11 Jun 2025

|

AFI Simposio: Rimini, IT | 11-13 Jun 2025

|

Antibody Industrial Symposium (AIS): Tours, FR | 25-26 Jun 2025

|

CPHI 2025: Frankfurt, DE | 28-30 Oct 2025

News

One LC-MS/MS method for four Cannabinoids

Cannabis and its medicinal use have long been discussed among the medical community and have been repeatedly called for by patient associations. However, cannabis was illegal in many countries and classified as an abuse drug. (...)

Kymos and Prolytic are CIR certified

In addition to Kymos, which has been CIR certified for quite some time, our German subsidiary Prolytic has been approved a CIR certification as well. Now your R&D activities (from Early Phase up to Phase (...)

Kymos Christmas Calendar

This year the whole team of Kymos has a Christmas surprise for our clients and partners: An Online Christmas Calendar (Click here) Click on the link and find the Christmas greetings from our individual departments. (...)

New FDA Draft Guideline for Oligonucleotide Therapeutics

In June 2022 the FDA published a draft version of a new guideline about “Clinical Pharmacology Considerations for the Development of Oligonucleotide Therapeutics”. The guideline provides recommendations to assist the industry in the development of (...)